11 results
424B3
BIAF
BioAffinity Technologies Inc
16 Apr 24
Prospectus supplement
7:19pm
countries, instability in the global credit markets, supply chain weaknesses, instability in the geopolitical environment as a result of the withdrawal … financial risks passed through the supply chain and disruptions that could result in increased prices for our products and the resources needed
POS AM
BIAF
BioAffinity Technologies Inc
1 Apr 24
Prospectus update (post-effective amendment)
8:06pm
, supply chain weaknesses, instability in the geopolitical environment as a result of the withdrawal of the United Kingdom from the European Union … for manufacturing and could increase insurance and other operating costs. We could also face indirect financial risks passed through the supply chain
424B4
BIAF
BioAffinity Technologies Inc
2 Sep 22
Prospectus supplement with pricing info
3:25pm
and may in the future experience disruptions from COVID-19 to our business in a number of ways, including:
delays in supply chain and manufacturing … of any third party in our supply chain for materials is adversely impacted by the COVID-19 pandemic, including due to staffing shortages, production
S-1
q8zk0
25 Apr 22
IPO registration
6:16am
- Prev
- 1
- Next